Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 GBX | +1.79% | 0.00% | +14.00% |
Apr. 03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
Mar. 27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Sales 2022 | 72.77M 90.44M | Sales 2023 | 59.59M 74.06M | Capitalization | 7.13M 8.86M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.16M | Net income 2023 | -43M -53.44M | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.41M | Net Debt 2023 | 21.14M 26.28M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 day | +2.86% | ||
1 week | +1.05% | ||
Current month | -4.00% | ||
1 month | +4.73% | ||
3 months | +44.00% | ||
6 months | +98.62% | ||
Current year | +15.20% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 09-06-30 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 22-03-31 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 17-06-05 | |
Peter Jensen
CHM | Chairman | 73 | 10-09-30 |
Anthony Parker
BRD | Director/Board Member | - | 22-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.85 | +1.79% | 917 879 |
24-04-23 | 2.8 | -1.75% | 948,754 |
24-04-22 | 2.85 | +7.55% | 668,040 |
24-04-19 | 2.65 | -7.02% | 1,429,952 |
24-04-18 | 2.85 | 0.00% | 610,104 |
Delayed Quote London S.E., April 24, 2024 at 04:42 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+15.20% | 166M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+3.35% | 22.19B | |
-16.16% | 21.33B | |
-7.31% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- AGY Stock